Hong Ma

Hong Ma

Company: CARsgen Therapeutics

Job title: Senior Vice President, Clinical Development


Zevor-cel (CT053) BCMA CAR-T Cells in Multiple Myeloma 11:30 am

Reporting the safety and efficacy of zevor-cel CAR-BCMA T cells (CT053) utilizing a newly identified, fully-human BCMA-specific scFv with fine-tuned binding affinity Zevor-cel showed low-level CD3 autophosphorylation and induced relatively lowlevel IL-6 secretion while displaying potent preclinical antitumor activities Sharing results from two registration studies (LUMMICAR-1 in China and LUMMICAR-2 in US and Canada)Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.